Clopidogrel and aspirin together (dual antiplatelet therapy or DAPT) is a standard treatment after heart attacks and stent placement, but the combination significantly increases bleeding risk. This is an intentional clinical trade-off between preventing clot formation and accepting higher bleeding risk.
How This Interaction Works (Mechanism)
Clopidogrel irreversibly blocks the P2Y12 ADP receptor on platelets, while aspirin irreversibly inhibits COX-1, preventing thromboxane A2 production. Together, they block two independent platelet activation pathways, providing more complete inhibition of platelet aggregation than either drug alone. This dual inhibition is essential for preventing stent thrombosis but approximately doubles the risk of major bleeding compared to aspirin alone.
Source: American College of Cardiology/American Heart Association DAPT Guidelines, 2024
Take this combination only as prescribed by your cardiologist, typically for 6 to 12 months after stent placement or a heart attack. Do not stop either medication without consulting your doctor, as premature discontinuation can cause stent thrombosis, which is often fatal. Report any unusual bleeding, dark stools, blood in urine, or prolonged bleeding from cuts. Avoid additional NSAIDs and limit alcohol intake.
Check More Drug Interactions
Use our free interaction checker to search thousands of drug, supplement, and food combinations.
Open Interaction CheckerEveryday safety with a blood thinner
As an Amazon Associate I earn from qualifying purchases.
Sources and standards behind this page
What a drug interaction does, and how strongly it is supported, is documented in public labeling and federal safety references rather than in any one summary, and the sources below are the primary ones. They are linked so a reader can check a claim without taking this page's word for it.
- DailyMed carries the current FDA labeling for every marketed drug product, including the warnings and drug interaction sections.
- Drugs@FDA is the federal database of approved drug products and their approval documents.
- FDA: Drug interactions, what you should know explains how drug-drug, drug-food and drug-condition interactions are described on labels.
- FDA Drug Safety Communications publishes the agency's safety alerts and label changes as they are issued.
- FDA MedWatch is the program for reporting and reviewing adverse events, including suspected interactions.
- openFDA provides public access to FDA labeling and adverse event data.
- MedlinePlus drug information is the National Library of Medicine's consumer reference for what a medicine is and how it is taken.
- NIAAA: Harmful interactions documents which medicines interact with alcohol and how.
- NCCIH: Herb-drug interactions summarises the evidence on interactions between herbal products and medicines.
- National Library of Medicine maintains the drug and health databases the sources above draw on.
This page describes how this interaction works and where it is documented. It is not medical advice: a prescriber or pharmacist decides what applies to a particular patient and medication.
Frequently Asked Questions
Clopidogrel and Aspirin have a moderate interaction that requires caution. While some patients may take both under medical supervision, the combination can cause adverse effects. Talk to your doctor before combining these medications, and do not adjust doses on your own.
Clopidogrel and aspirin together (dual antiplatelet therapy or DAPT) is a standard treatment after heart attacks and stent placement, but the combination significantly increases bleeding risk. This is an intentional clinical trade-off between preventing clot formation and accepting higher bleeding risk.
Yes. Anytime you are taking multiple medications, supplements, or substances, you should inform your doctor and pharmacist. They can evaluate your specific risk factors (age, kidney function, other medications, medical conditions) and determine whether the Clopidogrel and Aspirin combination is safe for you, or whether adjustments are needed.
Related Resources
Get Drug Safety Alerts
Leave your email for updates on FDA warnings, new drug interactions, and patient safety information. We have not started sending yet, and we will only email when we do.